| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $964K | — | -23.8% |
| Cost of Revenue | $674K | — | -47.5% |
| Gross Profit | $289K | — | +1590.5% |
| R&D Expense | $227K | — | -26.1% |
| SG&A Expense | $1.2M | — | -7.2% |
| Operating Income | -$1.8M | — | -0.4% |
| Income Tax | $23K | — | +124.9% |
| Net Income | -$2.7M | -47.3% | -38.6% |
| EPS (Basic) | -$0.09 | — | +62.5% |
| EPS (Diluted) | -$0.09 | — | +62.5% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.1M | — | — |
| Inventory | $1.4M | — | — |
| Current Assets | $3.4M | — | — |
| Total Assets | $6.4M | — | — |
| Current Liabilities | $8.7M | — | — |
| Long-term Debt | $5.3M | — | — |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.5M | — | — |
| Capital Expenditures | $85K | — | — |
| Investing Cash Flow | -$87K | — | — |
| Financing Cash Flow | $6.2M | — | — |
| Free Cash Flow | -$5.6M | — | — |
| Total Liabilities |
| $9.3M |
| — |
| — |
| Stockholders' Equity | -$3.0M | -197.5% | -6722.9% |